Fundraising Fox
/Companies
Sign in

Clade Therapeutics

Cambridge, US · Founded 2020 · Delaware corporation · 7 employees on LinkedIn · 10 known investors

Find your way into Clade Therapeutics

32 people in our graph share verified history with the Clade Therapeutics team — schools, employers, funds. One of them is your warm intro.

Freddie Dearunlockedknows Chad A. Cowan · together at Clade Therapeutics (overlapped)
knows the team · via Century Therapeutics, Inc.
×4knows the team · via Harvard Stem Cell Institute
knows the team · via Cellular Intelligence
×4knows the team · via Metagenomi
knows the team · via The University of Texas Southwestern Medical School
Biotech

Founders & leadership

Clade Therapeutics was founded in 2020 by Chad A. Cowan.

CAChad A. Cowan
Chad A. CowanFounder and Chief Executive Officer2020–2024Chad Cowan is an executive at Clade Therapeutics with background in biotech R&D and translational research, including expertise in stem cell research, iPSC cell therapy development, genetic engineering, and genome editing.
LV
Leandro VetcherNamed on SEC filing
DV
Daniel VasellaNamed on SEC filing
JG
Jim GlasheenNamed on SEC filing
NW
Neil WhiteNamed on SEC filing

Board

MM
Martin MurphyBoard director

Investors · 10

Synconalisted by SynconaLondon

How we know: Syncona's portfolio page · funding news · press coverage · Not right? Tell us

Bain Capital Life SciencesreportedBoston

How we know: biopharmadive.com · Not right? Tell us

Casdin CapitalreportedNew York

How we know: biopharmadive.com · Not right? Tell us

Venrock Healthcare Capital PartnersreportedNew York

How we know: biopharmadive.com · Not right? Tell us

Also in the syndicate · 5

Adage Capital Partners LPleadBoxer CapitalDAFNA Capital ManagementOctagon CapitalleadSuperstring Capitallead

Funding

SEC filings, press & company announcements

$45.9M disclosed across 2 of 3 rounds · 2021–2024

▶$42KraisedJan 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Chad A. CowanExecutive Officer, Director
  • Martin MurphyDirector
  • Daniel VasellaDirector
  • Jim GlasheenExecutive Officer, Director
  • Neil WhiteDirector
  • Leandro VetcherExecutive Officer
Offering amount
$66K
Amount sold
$42K
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45.9MraisedNov 2021 · 31 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Leandro VetcherExecutive Officer
  • Daniel VasellaDirector
  • Jim GlasheenExecutive Officer, Director
  • Neil WhiteDirector
  • Chad A. CowanExecutive Officer, Director
  • Martin MurphyDirector
Offering amount
$87.1M
Amount sold
$45.9M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Clade Therapeutics?
Clade Therapeutics was founded by Chad A. Cowan in 2020.
Who are Clade Therapeutics's investors?
Clade Therapeutics's investors include LifeSci Venture Partners, Syncona, Bain Capital Life Sciences, Casdin Capital, Venrock Healthcare Capital Partners.
How much funding has Clade Therapeutics raised?
Clade Therapeutics has disclosed $45.9M raised across 2 of its 3 known rounds.
Where is Clade Therapeutics headquartered?
Clade Therapeutics is headquartered in Cambridge, US.